Home Compare VRSK vs VRTX
Stock Comparison · Comparison

Verisk Analytics vs Vertex Pharmaceuticals: Which Stock Looks Stronger in 2026?

Vertex Pharmaceuticals holds the cleaner structural position, with stability as the main driver and growth adding further support. The market setup broadly confirms the structural lead — Vertex Pharmaceuticals holds the more constructive position. That puts structure and market broadly in agreement — Vertex Pharmaceuticals's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.

Updated 2026-07-05

The lead is spread across stability and growth, rather than sitting in one isolated gap. Vertex Pharmaceuticals Incorporated leads by 12 points on the overall comparison score.

Trajectory Similarity
0.57
Moderately similar
Peer-set rank: #38
within Verisk Analytics, Inc.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The strongest overlap appears in revenue stability and capital structure.

Similarity drivers
revenue stabilitycapital structure
What reduces the match
margin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
VRSK
Verisk Analytics, Inc.
55
Peer-Score
Signal qualitylow
Peer basis: S&P 500
vs
VRTX
Vertex Pharmaceuticals Incorporated
67
Peer-Score
Signal qualitylow
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: VRSK vs VRTX Profitability 75 78 Stability 46 79 Valuation 59 60 Growth 25 49 VRSK VRTX
Gap Ranking
#1 Stability +33
#2 Growth +24
#3 Profitability +3
#4 Valuation +1
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for VRSK and VRTX Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer VRSKVRTX Relative valuation Structural strength

The setup stays mixed because structure and the price setup do not align cleanly in one direction.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where VRSK and VRTX each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY VRSK Lower · below norm 0th 50th 100th 70 pct gap VRTX Elevated · above norm 0th 50th 100th 30th 99th
Today VRSK sits in the lower-middle of its own 5-year history (30th percentile), while VRTX sits higher in its own history (99th). Within each stock's own 5-year context, VRSK is at a historically more favourable entry position than VRTX. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Stability
Both rank well on stability, but Vertex Pharmaceuticals Incorporated still holds a clear edge.
Growth
Vertex Pharmaceuticals Incorporated holds the stronger peer position on growth.
Stability — Dominant Gap
VRSK
46
VRTX
79
Gap+33in favour of VRTX

The stability gap is wide, with the stronger side looking materially steadier through time.

What else supports the lead

Earnings growth is one contributing factor within the growth lead.

What this means for the comparison

Stability is the clearest driver, and growth also supports Vertex Pharmaceuticals Incorporated's broader structural position.

Explore full peer positioning in AssetNext

Break down the VRSK vs VRTX comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-and-growth comparisons

Explore how VRSK and VRTX each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.